Ten Tweet round up of exciting CAR T trial in patients with SLE discussed last month - check it out while you can!

Welcome to #TenTweetNephJC

✳️ 10 tweets #NephJC catch-up ✳️

Here’s a recap of our 25th Oct #NephJC discussion on ‘Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus’ - better late than never!

Check out the paper at https://t.co/HxTcVC3PtH pic.twitter.com/y7o71HUPiZ
— Nephrology Jrnl Club (@NephJC) November 18, 2022